US FDA warns online vendors selling unapproved weight-loss drugs

The U.S. Food and Drug Administration said on Tuesday it has sent warning letters to four companies for selling unapproved versions of GLP-1...
2 hours ago
from: Reuters

Anti-obesity medication, FDA warning letter, Food and Drug Administration, GLP-1 receptor agonist, Safety, Semaglutide, Weight loss

More about this

- FDA Roundup: December 17, 2024
PRNewswire/ --Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today,...
from: PR Newswire

- US FDA warns online vendors selling unapproved weight-loss drugs
(Reuters) - The U.S. Food and Drug Administration said on Tuesday it has sent warning letters to four companies for selling unapproved...
from: Yahoo